Anand Ashwin Patel (Anand A Patel, Anand Patel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 58

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Iron Deficiency

Top Venues

Blood cancer journal

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer, Adam S DuVall, Satyajit Kosuri, Michael J Thirman, Olatoyosi Odenike, Wendy Stock, Richard A Larson, Anand Ashwin Patel
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leukemia & lymphoma 65 (6) (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E Foucar, Rohan K Achar, Rory M Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand Ashwin Patel
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia. EJHaem 5 (4) (2024)
Chenyu Lin, Anand Ashwin Patel, Dezheng Huo, Theodore Karrison, Koen van Besien, John E Godwin, Dorie Sher, Howie Weiner, Margaret Green, James L Wade, Rebecca B Klisovic, Maria R Baer, Richard A Larson, Wendy Stock, Olatoyosi Odenike
A Multicenter Phase II Clinical Trial of Low-Dose Subcutaneous Decitabine in Myelofibrosis. Blood advances (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Andrew Stephen Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Nepheli Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Syed Shah, Hamed Rahmani Youshanlouei, Melissa L Larson, Maryam Zia, Stephanie B Tsai, Jessica K Altman, Wendy Stock, Irum Khan, Anand Ashwin Patel
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia. Blood advances 8 (17) (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer, Adam S DuVall, Satyajit Kosuri, Michael J Thirman, Olatoyosi Odenike, Wendy Stock, Richard A Larson, Anand Ashwin Patel
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leukemia & lymphoma 65 (6) (2024)
Noah Mehr, Christine Fuja, Cody Simon, Timothy Carll, Rahaf Alkhateb, Sulin Wu, Anand Ashwin Patel, Fatima Aldarweesh
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion 64 (6) (2024)
Noah Mehr, Christine Fuja, Cody Simon, Timothy Carll, Rahaf Alkhateb, Sulin Wu, Anand Ashwin Patel, Fatima Aldarweesh
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion 64 (6) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan Carlos Carlos Hernández-Boluda, Prithviraj Bose, Konstanze Döhner, Martin Ellis, Naseema Gangat, Jacqueline S Garcia, Heinz Gisslinger, Jason Gotlib, Paola Guglielmelli, Vikas K Gupta, Claire N Harrison, Elizabeth O Hexner, Gabriela S Hobbs, Jean-Jacques Kiladjian, Steffen Koschmieder, Nicolaus M Kröger, Andrew T Kuykendall, Giuseppe Gaetano Loscocco, John O Mascarenhas, Lucia Masarova, Ruben A Mesa, Barbara Mora, Olatoyosi Odenike, Stephen T Oh, Animesh D Pardanani, Anand Ashwin Patel, Naveen Pemmaraju, Alessandro Rambaldi, Raajit K Rampal, Shireen Sirhan, Natasha Szuber, Moshe Talpaz, Pankit Vachhani, Alessandro M Vannucchi, Tiziano Barbui
Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis. Blood (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer, Adam S DuVall, Satyajit Kosuri, Michael J Thirman, Olatoyosi Odenike, Wendy Stock, Richard A Larson, Anand Ashwin Patel
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leukemia & lymphoma (2024)
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E Foucar, Rohan K Achar, Rory M Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand Ashwin Patel
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia. EJHaem 5 (4) (2024)
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer, Adam S DuVall, Satyajit Kosuri, Michael J Thirman, Olatoyosi Odenike, Wendy Stock, Richard A Larson, Anand Ashwin Patel
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leukemia & lymphoma 65 (6) (2024)
Noah Mehr, Christine Fuja, Cody Simon, Timothy Carll, Rahaf Alkhateb, Sulin Wu, Anand Ashwin Patel, Fatima Aldarweesh
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Noah Mehr, Christine Fuja, Cody Simon, Timothy Carll, Rahaf Alkhateb, Sulin Wu, Anand Ashwin Patel, Fatima Aldarweesh
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion 64 (6) (2024)
Andrew Stephen Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Nepheli Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Syed Shah, Hamed Rahmani Youshanlouei, Melissa L Larson, Maryam Zia, Stephanie B Tsai, Jessica K Altman, Wendy Stock, Irum Khan, Anand Ashwin Patel
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia. Blood advances 8 (17) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances 8 (13) (2024)
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E Foucar, Rohan K Achar, Rory M Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand Ashwin Patel
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia. EJHaem 5 (4) (2024)
Talha Badar, Ravi Narra, Alice S Mims, Michael G Heckman, Rory M Shallis, Sheikh Fahad, Cameron Hunter, Vamsi K Kota, Tamer Adel Othman, Brian A Jonas, Shreya Desai, Guilherme Sacchi de Camargo Correia, Anand Ashwin Patel, Adam S DuVall, Neil Palmisiano, Emily Curran, Zulfa Omer, Anjali S Advani, Ehab Atallah, Mark R Litzow
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. American journal of hematology (2024)
Anand Ashwin Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory Michael Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K Rampal, Guru Subramanian Guru Murthy, Terrence J Bradley, Yasmin M Abaza, Jacqueline S Garcia, Vikas K Gupta, Kristen M Pettit, John F Cursio, Olatoyosi Odenike
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood advances (2024)
Andrew Stephen Palmer, Garth H Rauscher, Ivy Elizabeth Abraham, Madelyn Burkart, Ami Dave, Nepheli Ioanna Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Syed Abdul Mannan Shah, Hamed Rahmani Youshanlouei, Melissa L Larson, Maryam Zia, Stephanie B Tsai, Jessica K Altman, Wendy Stock, Irum Khan, Anand Ashwin Patel
Air Pollutant Impact on Disease Characteristics and Outcomes in Patients with Acute Myeloid Leukemia. Blood advances (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Farhad Ravandi, Asad Bashey, James M Foran, Wendy Stock, Raya Mawad, Nicholas James Short, Musa Ylimaz, Hagop M Kantarjian, Olatoyosi Odenike, Anand Ashwin Patel, Raman Garcha, William Barrett Ainsworth, Raphael Clynes, Jitendra Kanodia, Ying Ding, Huajiang Li, Steve Kye, Alice S Mims
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia. Blood advances (2023)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Rafael Madero-Marroquin, Adam S DuVall, Caner Saygin, Peng Wang, Sandeep Gurbuxani, Richard A Larson, Wendy Stock, Anand Ashwin Patel
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors. British journal of haematology (2023)
Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Anand Ashwin Patel, Adam S DuVall, Peng Wang, Pankhuri Wanjari, Jeremy P Segal, Girish Venkataraman, Jason Xiaojun Cheng, Sandeep K Gurbuxani, Angela M Lager, Carrie Fitzpatrick, Michael J Thirman, Mariam T Nawas, Hongtao Liu, Michael W Drazer, Olatoyosi Odenike, Richard A Larson, Wendy Stock, Caner Saygin
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults. Blood advances (2023)
Talha Badar, Ehab Atallah, Rory Michael Shallis, Antoine N Saliba, Anand Ashwin Patel, Jan P Bewersdorf, Justin Grenet, Maximilian Stahl, Adam Duvall, Madelyn Burkart, Neil Palmisiano, Danielle Bradshaw, Michal Kubiak, Shira Dinner, Aaron D Goldberg, Yasmin Abaza, Guru Subramanian Guru Murthy, Vamsi K Kota, Mark R Litzow
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia (2023)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, Bartholomew J Eisfelder, Anika T Thomas-Toth, Girish Venkataraman, Vijayalakshmi Ananthanarayanan, Tiffaney L Vincent, Adam S DuVall, Anand Ashwin Patel, Yi Chen, Fenlai Tan, Stephen P Anthony, Yu Chen, Yue Shen, Olatoyosi M Odenike, David Trent Teachey, Barbara L Kee, James L LaBelle, Wendy Stock
Dual targeting of apoptotic and signaling pathways in T-lineage acute lymphoblastic leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Evan C Chen, Hannah Johnston, Anand Ashwin Patel
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors. Current hematologic malignancy reports (2023)
Yuming Guo, Siyuan Xia, Junhong Xiang, Yuancheng Li, Matthew O Ross, Seon Ah Lim, Fan Yang, Jiayi Tu, Lishi Xie, Urszula Dougherty, Freya Q Zhang, Zhong Zheng, Rukang Zhang, Rong Wu, Lei Dong, Rui Su, Xiufen Chen, Thomas Althaus, Peter A Riedell, Patrick B Jonker, Alexander Muir, Gregory B Lesinski, Sarwish Rafiq, Madhav V Dhodapkar, Wendy Stock, Olatoyosi Odenike, Anand Ashwin Patel, Joseph T Opferman, Takemasa Tsuji, Junko Matsuzaki, Hardik Shah, Brandon Faubert, Shannon E Elf, Brian Layden, B Marc Bissonnette, Yu-Ying He, Justin Kline, Hui Mao, Kunle Odunsi, Xue Gao, Hongbo Chi, Chuan He, Jing Chen
Trans-vaccenic acid reprograms CD8 + T cells and anti-tumour immunity. Nature (2023)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Ehab Atallah, Rory M Shallis, Aaron D Goldberg, Anand Ashwin Patel, Yasmin Abaza, Jan Philipp Bewersdorf, Antoine N Saliba, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Adam Duvall, Madelyn Burkart, Maximilian Stahl, Yuanhang Liu, Shira Dinner, Neil Palmisiano, Mark R Litzow, James M Foran
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. American journal of hematology 97 (7) (2022)
Ivy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel, William B Pearse, Priya Rajakumar, Madelyn Burkart, Ahmed Aleem, Ami Dave, Sushma Bharadwaj, Koosha Paydary, Maria Acevedo-Mendez, Krishna Goparaju, Richard Gomez, Kylie Carlson, Stephanie B Tsai, John G Quigley, John P Galvin, Maryam Zia, Melissa L Larson, Stephanie Berg, Wendy Stock, Jessica K Altman, Irum Khan
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Blood 139 (14) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer (2022)
Jennifer H Cooperrider, Navika Shukla, Mariam T Nawas, Anand Ashwin Patel
The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia. JCO oncology practice (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Juan Alban, Adam S DuVall, Sandeep K Gurbuxani, Wendy Stock, Anand Ashwin Patel
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO precision oncology 6 (2022)
Anand Ashwin Patel, Joseph Heng, Emily Dworkin, Sarah Monick, Benjamin A Derman, Adam S DuVall, Sandeep Gurbuxani, Satyajit Kosuri, Hongtao Liu, Michael Thirman, Lucy A Godley, Olatoyosi Odenike, Richard A Larson, Wendy Stock
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults. EJHaem 2 (3) (2021)
Anand Ashwin Patel, Alexandra E Rojek, Michael W Drazer, Howard Weiner, Lucy A Godley, Michelle M Le Beau, Richard A Larson
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy. Blood advances 5 (20) (2021)
Anand Ashwin Patel, Kirk Cahill, Angella Charnot-Katsikas, Hongtao Liu, Sandeep Gurbuxani, Michael Thirman, Satyajit Kosuri, Andrew S Artz, Richard A Larson, Wendy Stock, Jeremy Segal, Olatoyosi Odenike
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib. British journal of haematology 190 (1) (2020)
Talha Badar, Aniko Szabo, Shira Dinner, Michaela Liedtke, Madelyn Burkart, Rory M Shallis, Ilana R Yurkiewicz, Eric Kuo, Muhammad Ali Khan, Suresh Balasubramanian, Jay Yang, Mehrdad Hefazi, Nikolai A Podoltsev, Anand Ashwin Patel, Emily Curran, Amy Wang, Shukaib Arslan, Ibrahim Aldoss, Caitlin Siebenaller, Ryan J Mattison, Mark R Litzow, Martha Wadleigh, Anjali S Advani, Ehab Atallah
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Cancer 127 (7) (2020)